Renol Polychem Limited
Renol Polychem Limited (RNPL): company summary
The company's business improved significantly, with annual revenue rising 44.4% to ₹90 crore and annual net profit increasing 65.0% to ₹8 crore.
Renol Polychem Limited (RNPL) is a micro-cap Chemicals company valued at ₹83 crore operating in Specialty Chemicals on the NSE and BSE.
- Recent price move
- Renol Polychem Limited last traded at ₹68.45, sharply down 5.00% on the day.
- Financial performance
- The company's business improved significantly, with annual revenue rising 44.4% to ₹90 crore and annual net profit increasing 65.0% to ₹8 crore. The latest quarter showed stronger growth, with revenue up 49.3% to ₹50 crore and net profit jumping 109.6% to ₹6 crore compared to the same quarter a year earlier. The net profit margin expanded 1.1 percentage points to 9.2%, while return on equity and return on capital employed remained at 7.6% and 9.1% respectively.
- Valuation multiples
- The stock trades at 10.0 times earnings, 0.79 times book value.
- Things to watch
- The stock is 56.4% below its 52-week high, and the company's market cap is ₹75 crore, classifying it as a micro-cap. Promoter holding is 51.10%, with no foreign or domestic institutional holdings.
- Where it stands
- The company's latest quarter net profit surged 109.6% to ₹6 crore, outpacing revenue growth of 49.3% to ₹50 crore. The stock is 56.4% below its 52-week high.
Summarised by DocStoX's model on 2026-10-04 from company filings, exchange data and news. This is a factual summary, not a rating or a recommendation. Informational only, not investment advice. Consult a SEBI-registered adviser before investing.
Price performance
Supported by risk (8.5) and valuation (8.2), but held back by momentum (0.0). Risk looks strong at 8.5, but that is offset by momentum at 0.0 and quality at 1.5. We are calling it Mixed rather than resolving the conflict for you. Scored on 4 of 5 measures.
DocStoX score
Low confidenceScored on 4 of 5 measures — the rest have no data for this company.
At a glance
Key highlights
- Low leverage — D/E 0.16
- Undemanding at 10× earnings
- Quality is weak (1.5/10)
- Momentum is weak (0.0/10)
Growth
Financials
Technicals
Peers
News
Forecasts
About the company
More data
Filings, corporate actions and ownership detail — opened on demand.
More Chemicals stocks · Specialty Chemicals
Explore Renol Polychem Limited’s valuation
Free deep-dive tools · no sign-up
Renol Polychem Limited peers in Chemicals
Other Chemicals stocks on the NSE & BSE. See the full Chemicals sector list.
Related tools & concepts
Value Renol Polychem Limited with the ratios and calculators DocStoX uses in its analysis.

